Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
VANCOUVER, British Columbia, Oct. 12, 2023 -- Mydecine Innovations Group, Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...